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ABSTRACT 
Azathioprine (50-150mg per day) and Methotrexate (2.5mg per week) are used in the 
treatment of cancer in adult Man. We evaluated the nephrotoxic effects of Azathioprine and 
Methotrexate in rats. Forty adult male wistar rats (150 - 230g) were used in the study. Group I 
was control. Experimental Groups II - V received oral administrations of 5mg/kg/bodyweight of 
Azathioprine per day, 15mg/kg/bodyweight of Azathioprine per day, 8mg/kg/bodyweight of 
Methotrexate per week and 20mg/kg/bodyweight of Methotrexate per week respectively for 35 
days. Histological examinations of the kidney showed dose-dependent morphological anomalies 
such as irregular cyto-architecture and decreased diameters of the Urinary Space, shrunk 
Glomeruli and necrotic cells in Groups II – V. Statistical analyses showed dose-dependent 
elevated levels (P≤0.05) of superoxide dismutase and malondialdehyde in kidney homogenates 
of Groups II – V when compared to Group I. This implied increased oxidative stress in rats of 
Groups II – V. Evaluations of creatinine and urea concentrations showed dose-dependent 
significantly elevated levels (P≤0.05) in Groups II – V when compared to Group I. This study 
provided further evidence that the nephrotoxic activities of Azathioprine and Methotrexate could 
be due to generated increased oxidative stress, which resulted in impaired morphology and 
functions of the kidney in rats. 
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INTRODUCTION 
The final product of the glomerular filtration 
processes is urine (about 1500mls per day), 
which contains eliminated waste metabolic 
products (Junqueira and Carneiro, 2007). 
Renal diseases are implicated in a great 
percentage of morbidity and renal failures 
are of serious economic burden globally. 
(Kumar et al, 2004). The four basic 
morphologic components of the kidney: 
glomeruli, tubules, interstitium and blood 
vessels could be affected in immune-
mediated disorders or exposures to toxic and 
infectious agents leading to impaired renal 
functions (Kumar et al., 2004).  
 
Azathioprine is an immunosuppressant drug, 
which is used to inhibit the body’s rejection 
of transplanted tissues (Tripathi, 2003; 
British National Formulary, 2013).  It 
interferes with the synthesis of 
deoxyribonucleic acid (DNA), gives rise to 
non-functional DNA and ribonucleic acid 
(RNA), inhibits the proliferation of T- and B- 
lymphocytes and suppresses bone marrow 
activities. (Tripathi, 2003; British National 
Formulary, 2013). Due to its antiproliferative 
activity, Azathioprine is used in the treatment 
of cancer. (Tripathi, 2003; British National 
Formulary, 2013). Methotrexate is a folic 
acid antagonist which inhibits dihydrofolate 
reductase and prevents the formation of 
tetrahydrofolic acid (THFA); thereby 
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inhibiting DNA replication, cellular 
hyperplasia, lymphocytes and macrophage 
functions. (Tripathi, 2003; British National 
Formulary, 2013). It is used in the treatment 
of cancer, rheumatoid arthritis and 
autoimmune diseases. (Tripathi, 2003; 
British National Formulary, 2013).  
 
Azathioprine and Methotrexate are classified 
as cytotoxic drugs with reported adverse 
effects such as oxidative damages to the 
DNA/RNA and body organs (Blaisiak et al., 
2002; Tripathi, 2003; Elelaimy et al., 2012). 
Furthermore, Ljuca et al., 2009 observed 
statistically significant higher serum 
creatinine, but lower glomerular filtration 
rate (GFR) and creatinine clearance in 
individuals treated with Azathioprine when 
compared with those treated with 
Mycophenolate Mofetil in patients that 
underwent kidney transplantation while 
Elelaimy et al., 2012 noted adverse effects of 
Azathioprine on the antioxidant status of 
kidney in rats. Similarly, impaired anomalies 
of renal convoluted tubules and glomeruli 
were observed in Methotrexate - treated 
mice. (Chelab and Majeed, 2009).  
Genotoxic and cytotoxic agents such as 
Azathioprine and Methotrexate would clearly 
affect the kidney like other body tissues 
structurally and functionally. We are not 
aware of any previous study that evaluated 
the combined effects of Azathioprine or 
Methotrexate as cytotoxic drugs on the 
morphology, antioxidant and functional 
status of the kidney in rats. For further 
considerations of the nephrotoxicity profile of 
Azathioprine and Methotrexate as anticancer 
drugs, this study was undertaken to provide 
further evidence on the possible effects of 
Azathioprine and Methotrexate on the 
morphology, antioxidant status and functions 




MATERIALS AND METHODS 
Ethical Approval  
Ethical approval was sought and received 
from the Department of Anatomy of the 
University of Ilorin, Ilorin, Kwara State, 
Nigeria. The protocols for the use of 
animals in scientific research were strictly 
adhered to in compliance with World Health 
Organization’s provisions.  
 
Animal Care and Feeding  
Forty apparently healthy adult male wistar 
rats weighing 150 - 230g and aged 10 – 12 
weeks obtained from the colony bred of the 
animal house of the Department of 
Anatomy, University of Ilorin were 
employed in the study. They were housed 
in individual cages in a well - ventilated and 
fumigated room with ambient temperature 
and good lighting. All rats were fed with 
standard pellet diet (Kusa Ventures Nigeria 
Limited, Ilorin) and received water ad 
libitum. The rats were acclimatized for 
seven days before the start of experimental 
procedures. The weight of each rat was 
taken daily using the high precision 
electronic analytical weighing balance 
(Denver, USA). Each rat was examined daily 
for possible behavioural and gross 
morphological or physical changes.  
 
Chemicals, Reagents and Laboratory 
Equipment  
Azathioprine 50mg (Imuran) and 
Methotrexate 2.5mg (Neotrexate) tablets 
were products of GlaxoSmithKline, United 
Kingdom; Normal saline solution, Distilled 
water, Phosphate buffer, EDTA, Sulphuric 
(VI) acid (H2SO4), and Hydrochloric acid 
(HCI) were products of BDH Chemical 
Limited, Poole, England; Tris buffers, 2-
thiobarbituric acid (TBA), Phosphoric acid 
and Pyrogallol were products of Sigma 
Chemicals, St. Louis USA; assay kit for 
Superoxide dismutase Activity was a 
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product of Randox Laboratories, United 
Kingdom; and assay kits for Creatinine and 
Urea Analyses were products of AGAPPE 
Diagnostic Limited, India. 
Spectrophotometer (Jenway Model 6405, 
UV/visible), mortar and pestle, weighing 
balance, centrifuge, pH meter (Rex model 
pHs 25), Norm-jet needles and syringes 
(Norm-jet Inc. Tuttlinger, Germany) and 
anticoagulant tubes (Sterling products, 
England).  
 
Administration of Drugs  
The treatment dosage of Azathioprine is 50 
- 150mg daily and that of Methotrexate is 
2.5mg per week in Man. Azathioprine 50mg 
(Imuran) and Methotrexate 2.5mg 
(Neotrexate) drug tablets were grinded into 
powdery forms using sizeable mortar and 
pestle in an environment free of wind and 
then dissolved in 10mls of distilled water. 
The male wistar rats employed in the study 
(n = 40) were divided into five groups; each 
comprising of eight rats. Rats of Control 
Group I received oral administration of 
distilled water daily. Rats of Experimental 
Groups II – V, however, received 
corresponding oral administrations of 
5mg/kg/body weight of Azathioprine per 
day, 15mg/kg/body weight of Azathioprine 
per day, 8mg/kg/body weight of 
Methotrexate per week and 20mg/kg/body 
weight of Methotrexate per week 
respectively for 35 days. Doses of 
administered drugs were determined from 
previous studies that determined the 
toxicity profiles of Azathioprine or 
Methotrexate using same or similar doses in 
rat models. (Padmanabhan et al., 2009; 
Elelaimy et al., 2012). Oral administration of 
drugs was done with the use of a 5ml 
syringe and a flexible feeding tube long 
enough to reach the stomach through the 
oesophagus.  
 
Excision and Fixation of the Kidney  
The rats of Groups I - V were sacrificed on 
Day 35 by humane method using 
chloroform inhalation. The animals were 
kept in a dessicator with cotton wool soaked 
in chloroform. The kidneys were harvested 
after incisions were made to expose the 
thoracic and abdominal cavities. The 
kidneys were removed, taken out and fixed 
in 10% formal saline of at least five times 
its volume. (Kiernan, 1990). Blood samples 
were obtained through the exposed thoracic 
cavities from the ventricles of the heart and 
centrifuged immediately for biochemical 
analyses. (Kiernan, 1990).   
 
Histological Analyses of the Kidney Tissues 
of Rats of Groups I – V  
Histological examinations of the fixed kidney 
of rats of Groups I – V were carried out 
using Haematological and Eosin techniques 
as earlier described. (Kiernan, 1990).  After 
complete fixation of the kidney, blocks were 
embedded in paraffin wax and sections cut 
at 5µm (micron). The tissue sections were 
stained with haematoxylin and eosin and 
mounted in Canada balsam. (Kiernan, 1990).  
Microscopic examination of the sections was 
then carried out under the Olympus light 
microscope to determine possible 
cytoarchitectural changes of the kidney 
following administrations of Azathioprine or 
Methotrexate. Photomicrographs of kidney 
samples were obtained with the aid of a 
digital camera (CANON Digital Camera, 
USA) attached to the Olympus light 
microscope.  
 
Preparations of the Kidney and Sera 
samples for Biochemical Analyses.  
The kidney of each rat was cut into small 
pieces, placed in a mortar and 0.1M 
phosphate buffer (extracting solution) of at 
least four times the volume of the organ 
was added. The organ was homogenized 
into a fine solution with the use of mortar 
and pestle. The homogenate was poured 
into a test tube and centrifuged at 10,000 
revolutions per minute for 10 minutes. The 
supernatant was carefully removed and the 
residue was discarded. The supernatant 
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served as the sample for the estimations of 
Superoxide dismutase activities and 
Malondialdehyde concentrations. Similarly, 
blood samples were centrifuged to separate 
the serum from the red blood cells and the 
serum was stored away for estimation of 
Creatinine and Urea concentrations.  
 
Determination of Superoxide dismutase 
Activities in Kidney Homogenates 
 
Superoxide dismutase activities in kidney 
homogenates of rats of Groups I – V were 
determined based on the protocol described 
in the assay kit of Randox Laboratories 
Limited. (United Kingdom).  
 
Determination of Lipid Peroxidation Status 
(Malondialdehyde Levels) in Kidney 
Homogenates 
The thiobarbituric acid assay (TBARS assay) 
method was used to quantify 
Malondialdehyde concentrations in kidney 
homogenates of rats of Groups I – V as 
earlier described by Akinlolu et al., 2012.  
 
Determination of Serum Creatinine 
Concentrations  
Creatinine concentrations in sera samples of 
rats of Groups I – V were determined based 
on the protocol described in the assay kit of 
AGAPPE Diagnostic Limited, India. (4 X 
50mL, Number 510009001).  
 
Determination of Serum Urea 
Concentrations 
 Urea concentrations in sera samples of rats 
of Groups I – V were determined based on 
the protocol described in the assay kits of 
AGAPPE Diagnostic Limited, India. (4 X 
50mL Number 5141101 and 4 X 100mL, 
Number 51411002).  
 
Statistical Analyses  
The Mean ± S.E.M (S.E.M. = Standard Error 
of Mean) value of each of the measured 
parameters of kidney functions (Creatinine 
and Urea concentrations) and antioxidant 
status (Superoxide dismutase and 
Malondialdehyde Levels) in rats of Control 
Group I were compared with rats of 
Experimental Groups II - V for any 
significant difference using the Student’s t-
test for unpaired samples. P values of 0.05 
(or less) were taken as statistically 
significant. Computed data were analysed 




Changes in Gross Morphology, Behavioural 
Activities and Average Bodyweight (g) of 
Rats of Groups I - V During Experimental 
Procedure.  
No anomalies of gross morphology and 
behavioural activities were observed in rats 
of Control Group I and Experimental Groups 
II – V. Comparison of the average 
bodyweights of rats of Group I (Day 1 
versus Day 35) showed statistically 
significant increased bodyweight (P≤0.05) 
at the end of five weeks of experimental 
procedures (Table 1). In contrast, there was 
a statistically non-significant decreased 
average bodyweight (P≤0.05) in rats of 
Groups II – IV [Day 1 versus Day 35](Table 
1). However, comparison of the average 
bodyweights of rats of Group V (Day 1 
versus Day 35) showed statistically 
significant decreased bodyweight (P≤0.05) 
at the end of five weeks of experimental 
procedures (Table 1).  No anomaly of gross 
morphology of the kidneys was observed in 
rats of Groups I – V when they were 
dissected and removed for histological and 
biochemical analyses. 
 
Histological Evaluations of the Kidneys of 
Rats of Control and Experimental Groups I – 
V.  
Examinations of the kidneys of rats of 
Control Group 1 showed normal histology 
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(Figure 1). Dose-dependent morphological 
anomalies such as disrupted 
cytoarchitecture of the kidney, ruptured 
Urinary Space of Bowman’s capsule towards 
the Vascular pole, shrunk Glomeruli and 
necrotic cells were observed in 
Azathioprine-treated rats of Groups II and 
III (Figures 2 and 3). Dose-dependent 
significant and non-significant decreases 
(P≤0.05) in glomeruli length and width 
respectively were observed in comparisons 
of Control Group I with Experimental 
Groups II – V (Table 2). Dose-dependent 
irregular cytoarchitecture and decreased 
diameter of Urinary Space of Bowman’s 
capsules were observed in Methotrexate-
treated rats of Groups IV and V. (Figures 4 
and 5).  
 
Evaluations of Superoxide dismutase (SOD) 
Activities  
Analyses of SOD activities in kidney 
homogenates of rats of Experimental 
Groups II - V showed statistically non-
significant higher activities (P≤0.05) of SOD 
when compared to rats of Control Group I. 
(Table 3). 
 
Evaluations of Lipid peroxidation Status 
(Malondialdehyde Concentrations)  
Analyses of Malondialdehyde Concentrations 
in kidney homogenates of rats of 
Experimental Groups II - V showed 
statistically significant higher concentrations 
(P≤0.05) of Malondialdehyde when 









Figure 1: Photomicrograph sample of the 
kidney of rats of Control Group I which 
received distilled    water. (a) Haematoxylin 
and Eosin X 200.   PCT = Proximal 
Convoluted Tubule, DCT = Distal Convoluted 
Tubule, PL = Parietal Layer of Bowman’s 
capsule, VL = Visceral Layer of Bowman’s 
Capsule, US = Urinary Space, G = Glomerulus 
and VP = Vascular Pole.   The 
cytoarchitecture of the kidney appeared 
normal. 
 
Figure 2: Photomicrograph sample of the kidney 
of rats of Experimental Group II which received 
5mg/kg/bodyweight of Azathioprine.  
Haematoxylin and Eosin X 200.  PCT = Proximal 
Convoluted Tubule, DCT = Distal Convoluted 
Tubule, PL = Parietal Layer of Bowman’s capsule, 
VL = Visceral Layer of Bowman’s Capsule, US = 
Urinary Space,               G = Glomerulus and VP 
= Vascular Pole. The cytoarchitecture of the 
kidney appeared disrupted and some necrotic 
cells could be observed in the kidney tissue. 
 







































Figure 5:     Photomicrograph samples of the kidney of rats of Experimental Group V 
which received 20mg/kg/bodyweight of Methotrexate. (a) Haematoxylin and Eosin X 
200.    PCT = Proximal Convoluted Tubule, DCT = Distal Convoluted Tubule, PL = 
Parietal Layer of Bowman’s Capsule, VL = Visceral Layer of Bowman’s Capsule, US = 
Urinary Space, G = Glomerulus and VP = Vascular Pole. The diameter of Urinary Space 
of Bowman’s capsule was markedly reduced. 
 
 
Figure 3:  Photomicrograph sample of the kidney 
of rats of Experimental Group III which received    
15mg/kg/bodyweight of Azathioprine. 
Haematoxylin and Eosin X 200.  PCT = Proximal 
Convoluted Tubule, DCT = Distal Convoluted 
Tubule, PL = Parietal Layer of Bowman’s Capsule, 
VL = Visceral Layer of Bowman’s Capsule, US = 
Urinary Space,           G = Glomerulus and VP = 
Vascular Pole.  The cytoarchitecture of the kidney 
appeared disrupted. The Glomerulus appeared 
shrunk and some necrotic cells were observed in 
the kidney tissue. 
 
Figure 4:  Photomicrograph samples of the 
kidney of rats of Experimental Group IV which 
received 8mg/kg/bodyweight of Methotrexate. 
(a) Haematoxylin and Eosin X 200.  PCT = 
Proximal Convoluted Tubule, DCT = Distal 
Convoluted Tubule, PL = Parietal Layer of 
Bowman’s Capsule, VL = Visceral Layer of 
Bowman’s Capsule, US = Urinary Space, G = 
Glomerulus and VP = Vascular Pole.  The 
diameter of the Urinary Space was reduced 
while the Bowman’s capsule appeared 
irregular. 
 































Table 1:  Changes in Bodyweight (g) of Rats of Control and Experimental Groups I – V 
During Experimental Procedure.  
Groups of rats Dose of Drugs Day 1 
 
Day 35 


















Figure 6: Creatinine Concentrations (mg/dl) in Sera Samples of Rats of Control and Experimental Groups I - V. 
 B.W. = Bodyweight, SEM = Standard Error of Mean. 
 



































Table 2:  SOD Activities and Malondialdehyde Concentrations in Kidney Homogenates of 










Statistical Significance at 
P≤0.05. (Group I vs. 
Group II or IV) 
I Distilled water 2.6±0.1 30.0±0.1  
II 5mg/kg/bodyweight 
Azathioprine 
2.91±0.2 39.5±1.5 YES 
IV 8mg/kg/bodyweight 
Methotrexate 
2.56±0.1 36.0±1.0 YES 
Figure 7: Urea Concentrations (mg/dl) in Sera Samples of Rats of Control and Experimental Groups I - V. B.W. = 
Bodyweight, SEM = Standard Error of Mean. 
 




Table 3: SOD Activities and Malondialdehyde Concentrations in Kidney Homogenates of Rats of Control 










Statistical Significance at 
P≤0.05. (Group I vs. 
Group II or IV) 
I Distilled water 2.6±0.1 30.0±0.1  
II 5mg/kg/bodyweight 
Azathioprine 
2.91±0.2 39.5±1.5 YES 
IV 8mg/kg/bodyweight 
Methotrexate 
2.56±0.1 36.0±1.0 YES 
 
Evaluations of Kidney Functions Tests 
(Creatinine Concentrations) 
Evaluations of serum Creatinine levels in 
rats of Experimental Groups II - V showed 
statistically significant higher levels 
(P≤0.05) when compared to rats of Control 
Group I  (Figure 6).  
Evaluations of Kidney Functions Tests (Urea 
Concentrations) 
Evaluations of serum Urea levels in rats of 
Experimental Groups II - V showed 
statistically significant higher levels 
(P≤0.05) when compared to rats of Control 
Group I (Figure 7). 
 
DISCUSSION 
Our findings showed no anomalies of gross 
morphology and behavioural activities in 
rats of Control Group I and Experimental 
Groups II – V. However, statistically non-
significant decreased average bodyweights 
(Groups II – IV) and significant decreased 
average bodyweights (Group V) were 
observed in rats of experimental groups in 
comparison of average bodyweights (Day 1 
versus Day 35) at P≤0.05. (Table 1).  The 
observed weight loss in rats of Groups II – 
V could possibly be due to inhibition of DNA 
syntheses and increased oxidative stress 
with consequent cellular damage of body 
organs in affected rats. This agreed with the 
works of Rusell and Rusell, 1991 which 
reported weight loss in rats exposed to 
cytotoxic agents such as Azathioprine and 
Methotrexate.  
 
Histological examinations of the kidney 
showed dose-dependent morphological 
anomalies such as irregular cyto-
architecture and decreased diameters of the 
Urinary Space, shrunk Glomeruli and 
necrotic cells in Groups II – V. Cellular 
necrosis results from compromise of the 
structural and functional integrity of 
membranes and is induced by sudden 
environmental insults with accompanied 
deranged physiological conditions. (Kumar 
et al., 2004). Our results possibly implied 
kidney anomalies via DNA or chromosomal 
damage following administrations of 
Azathioprine and Methotrexate which 
probably resulted in cellular necrosis and 
impaired glomerular membranes. Our 
observations are in agreement with 
previous studies which reported impaired 
anomalies of renal convoluted tubules and 
glomeruli in Methotrexate - treated mice. 
(Chelab and Majeed, 2009). 
 
Evaluations of the antioxidant status of the 
kidney showed significant higher activities 
(P≤0.05) of SOD and malondialdehyde 
levels (Table 3) in renal tissues of rats of 
Experimental Groups II - V when compared 
to rats of Control Group I. This implied 
increased oxidative stress in renal tissues of 
rats of Groups II – V. Increased lipid 
peroxidation is associated with oxidative 
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stress, compromised cell membranes and 
cellular damage in organisms. (Akinlolu et 
al., 2012).  The observed morphological 
anomalies of the kidneys of rats of Groups 
II – V could, therefore, have been due to 
Azathioprine or Methotrexate – induced 
oxidative stress. This is in agreement with 
previous studies which reported increased 
levels of superoxide dismutase and lipid 
peroxidation in Methotrexate – treated rats 
(Asvadi et al., 2011) or Azathioprine-treated 
rats (Elelaimy et al, 2012).  
 
We observed statistically significant higher 
levels of creatinine and urea (P≤0.05) in 
rats of Experimental Groups II – V when 
compared to rats of Control Group I. 
(Figures 6 and 7). Creatinine and urea 
levels provide one of the direct 
measurements of glomerular filtration rate 
and when elevated are indicative of kidney 
damage. (Nwangwu et al., 2011; Nwangwa, 
2012). Our findings, therefore, suggest 
possible compromise of the integrity of 
glomerular membranes and impaired 
functional status of the kidneys in 
Azathioprine or Methotrexate-treated rats 
resulting in poor glomerular filtration 
activities of the kidney. (Junqueira and 
Carneiro, 2007; Guyton and Hall, 2011).   
 
This is in agreement with previous studies 
which reported statistically significant higher 
serum creatinine, but lower glomerular 
filtration rate (GFR) and creatinine 
clearance in individuals treated with 
Azathioprine when compared with those 
treated with Mycophenolate Mofetil in 
patients that underwent kidney 
transplantation (Ljuca et al, 2009); and 
statistically significant higher serum 
creatinine and urea in Methotrexate-treated 
rats (Asvadi et al., 2011).  
 
Our observations on the combined effects of 
Azathioprine or Methotrexate as cytotoxic 
drugs on the morphology, antioxidant and 
functional status of the kidney in rats have 
not been previously reported. This study, 
therefore, provided further evidence that 
the nephrotoxic profiles of Azathioprine and 
Methotrexate could be due to generation of 
reactive oxygen species with consequent 
adverse effects on the cytoarchitectural 
components and functions of the kidney 
leading to poor glomerular filtration. We 
concluded that Azathioprine and 
Methotrexate administrations impaired the 
morphology and functions of the kidney in 
adult male wistar rats. 
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